The global market for Benign Prostatic Hyperplasic Device is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Benign Prostatic Hyperplasic Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Benign Prostatic Hyperplasic Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Benign Prostatic Hyperplasic Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Benign Prostatic Hyperplasic Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Benign Prostatic Hyperplasic Device players cover KARL STORZ SE, Richard Wolf GmbH, Olympus Corporation, Urologix and Boston Scientific Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Benign Prostatic Hyperplasic Device market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Benign Prostatic Hyperplasic Device market, with both quantitative and qualitative data, to help readers understand how the Benign Prostatic Hyperplasic Device market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Benign Prostatic Hyperplasic Device market and forecasts the market size by Type (Radiofrequency Ablation Devices, Urology Lasers Devices and Others), by Application (Hospitals, Clinics and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Radiofrequency Ablation Devices
Urology Lasers Devices
Others
Segmentation by application
Hospitals
Clinics
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
KARL STORZ SE
Richard Wolf GmbH
Olympus Corporation
Urologix
Boston Scientific Corporation
Butterfly
TELEFLEX Incorporated
OmniGuide Holdings
Convergent Laser Technologies
ProArc
Olympus Corporation
Chapter Introduction
Chapter 1: Scope of Benign Prostatic Hyperplasic Device, Research Methodology, etc.
Chapter 2: Executive Summary, global Benign Prostatic Hyperplasic Device market size (sales and revenue) and CAGR, Benign Prostatic Hyperplasic Device market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Benign Prostatic Hyperplasic Device sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Benign Prostatic Hyperplasic Device sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Benign Prostatic Hyperplasic Device market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including KARL STORZ SE, Richard Wolf GmbH, Olympus Corporation, Urologix, Boston Scientific Corporation, Butterfly, TELEFLEX Incorporated, OmniGuide Holdings and Convergent Laser Technologies, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Benign Prostatic Hyperplasic Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Benign Prostatic Hyperplasic Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Benign Prostatic Hyperplasic Device by Country/Region, 2017, 2022 & 2028
2.2 Benign Prostatic Hyperplasic Device Segment by Type
2.2.1 Radiofrequency Ablation Devices
2.2.2 Urology Lasers Devices
2.2.3 Others
2.3 Benign Prostatic Hyperplasic Device Sales by Type
2.3.1 Global Benign Prostatic Hyperplasic Device Sales Market Share by Type (2017-2022)
2.3.2 Global Benign Prostatic Hyperplasic Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Benign Prostatic Hyperplasic Device Sale Price by Type (2017-2022)
2.4 Benign Prostatic Hyperplasic Device Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Benign Prostatic Hyperplasic Device Sales by Application
2.5.1 Global Benign Prostatic Hyperplasic Device Sale Market Share by Application (2017-2022)
2.5.2 Global Benign Prostatic Hyperplasic Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Benign Prostatic Hyperplasic Device Sale Price by Application (2017-2022)
3 Global Benign Prostatic Hyperplasic Device by Company
3.1 Global Benign Prostatic Hyperplasic Device Breakdown Data by Company
3.1.1 Global Benign Prostatic Hyperplasic Device Annual Sales by Company (2020-2022)
3.1.2 Global Benign Prostatic Hyperplasic Device Sales Market Share by Company (2020-2022)
3.2 Global Benign Prostatic Hyperplasic Device Annual Revenue by Company (2020-2022)
3.2.1 Global Benign Prostatic Hyperplasic Device Revenue by Company (2020-2022)
3.2.2 Global Benign Prostatic Hyperplasic Device Revenue Market Share by Company (2020-2022)
3.3 Global Benign Prostatic Hyperplasic Device Sale Price by Company
3.4 Key Manufacturers Benign Prostatic Hyperplasic Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Benign Prostatic Hyperplasic Device Product Location Distribution
3.4.2 Players Benign Prostatic Hyperplasic Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Benign Prostatic Hyperplasic Device by Geographic Region
4.1 World Historic Benign Prostatic Hyperplasic Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Benign Prostatic Hyperplasic Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Benign Prostatic Hyperplasic Device Annual Revenue by Geographic Region
4.2 World Historic Benign Prostatic Hyperplasic Device Market Size by Country/Region (2017-2022)
4.2.1 Global Benign Prostatic Hyperplasic Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Benign Prostatic Hyperplasic Device Annual Revenue by Country/Region
4.3 Americas Benign Prostatic Hyperplasic Device Sales Growth
4.4 APAC Benign Prostatic Hyperplasic Device Sales Growth
4.5 Europe Benign Prostatic Hyperplasic Device Sales Growth
4.6 Middle East & Africa Benign Prostatic Hyperplasic Device Sales Growth
5 Americas
5.1 Americas Benign Prostatic Hyperplasic Device Sales by Country
5.1.1 Americas Benign Prostatic Hyperplasic Device Sales by Country (2017-2022)
5.1.2 Americas Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022)
5.2 Americas Benign Prostatic Hyperplasic Device Sales by Type
5.3 Americas Benign Prostatic Hyperplasic Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Benign Prostatic Hyperplasic Device Sales by Region
6.1.1 APAC Benign Prostatic Hyperplasic Device Sales by Region (2017-2022)
6.1.2 APAC Benign Prostatic Hyperplasic Device Revenue by Region (2017-2022)
6.2 APAC Benign Prostatic Hyperplasic Device Sales by Type
6.3 APAC Benign Prostatic Hyperplasic Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Benign Prostatic Hyperplasic Device by Country
7.1.1 Europe Benign Prostatic Hyperplasic Device Sales by Country (2017-2022)
7.1.2 Europe Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022)
7.2 Europe Benign Prostatic Hyperplasic Device Sales by Type
7.3 Europe Benign Prostatic Hyperplasic Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Benign Prostatic Hyperplasic Device by Country
8.1.1 Middle East & Africa Benign Prostatic Hyperplasic Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Benign Prostatic Hyperplasic Device Sales by Type
8.3 Middle East & Africa Benign Prostatic Hyperplasic Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasic Device
10.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasic Device
10.4 Industry Chain Structure of Benign Prostatic Hyperplasic Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Benign Prostatic Hyperplasic Device Distributors
11.3 Benign Prostatic Hyperplasic Device Customer
12 World Forecast Review for Benign Prostatic Hyperplasic Device by Geographic Region
12.1 Global Benign Prostatic Hyperplasic Device Market Size Forecast by Region
12.1.1 Global Benign Prostatic Hyperplasic Device Forecast by Region (2023-2028)
12.1.2 Global Benign Prostatic Hyperplasic Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Benign Prostatic Hyperplasic Device Forecast by Type
12.7 Global Benign Prostatic Hyperplasic Device Forecast by Application
13 Key Players Analysis
13.1 KARL STORZ SE
13.1.1 KARL STORZ SE Company Information
13.1.2 KARL STORZ SE Benign Prostatic Hyperplasic Device Product Offered
13.1.3 KARL STORZ SE Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 KARL STORZ SE Main Business Overview
13.1.5 KARL STORZ SE Latest Developments
13.2 Richard Wolf GmbH
13.2.1 Richard Wolf GmbH Company Information
13.2.2 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Product Offered
13.2.3 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Richard Wolf GmbH Main Business Overview
13.2.5 Richard Wolf GmbH Latest Developments
13.3 Olympus Corporation
13.3.1 Olympus Corporation Company Information
13.3.2 Olympus Corporation Benign Prostatic Hyperplasic Device Product Offered
13.3.3 Olympus Corporation Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Olympus Corporation Main Business Overview
13.3.5 Olympus Corporation Latest Developments
13.4 Urologix
13.4.1 Urologix Company Information
13.4.2 Urologix Benign Prostatic Hyperplasic Device Product Offered
13.4.3 Urologix Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Urologix Main Business Overview
13.4.5 Urologix Latest Developments
13.5 Boston Scientific Corporation
13.5.1 Boston Scientific Corporation Company Information
13.5.2 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Product Offered
13.5.3 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Boston Scientific Corporation Main Business Overview
13.5.5 Boston Scientific Corporation Latest Developments
13.6 Butterfly
13.6.1 Butterfly Company Information
13.6.2 Butterfly Benign Prostatic Hyperplasic Device Product Offered
13.6.3 Butterfly Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Butterfly Main Business Overview
13.6.5 Butterfly Latest Developments
13.7 TELEFLEX Incorporated
13.7.1 TELEFLEX Incorporated Company Information
13.7.2 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Product Offered
13.7.3 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 TELEFLEX Incorporated Main Business Overview
13.7.5 TELEFLEX Incorporated Latest Developments
13.8 OmniGuide Holdings
13.8.1 OmniGuide Holdings Company Information
13.8.2 OmniGuide Holdings Benign Prostatic Hyperplasic Device Product Offered
13.8.3 OmniGuide Holdings Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 OmniGuide Holdings Main Business Overview
13.8.5 OmniGuide Holdings Latest Developments
13.9 Convergent Laser Technologies
13.9.1 Convergent Laser Technologies Company Information
13.9.2 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Product Offered
13.9.3 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Convergent Laser Technologies Main Business Overview
13.9.5 Convergent Laser Technologies Latest Developments
13.10 ProArc
13.10.1 ProArc Company Information
13.10.2 ProArc Benign Prostatic Hyperplasic Device Product Offered
13.10.3 ProArc Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 ProArc Main Business Overview
13.10.5 ProArc Latest Developments
13.11 Olympus Corporation
13.11.1 Olympus Corporation Company Information
13.11.2 Olympus Corporation Benign Prostatic Hyperplasic Device Product Offered
13.11.3 Olympus Corporation Benign Prostatic Hyperplasic Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Olympus Corporation Main Business Overview
13.11.5 Olympus Corporation Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Benign Prostatic Hyperplasic Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Benign Prostatic Hyperplasic Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Radiofrequency Ablation Devices
Table 4. Major Players of Urology Lasers Devices
Table 5. Major Players of Others
Table 6. Global Benign Prostatic Hyperplasic Device Sales by Type (2017-2022) & (K Units)
Table 7. Global Benign Prostatic Hyperplasic Device Sales Market Share by Type (2017-2022)
Table 8. Global Benign Prostatic Hyperplasic Device Revenue by Type (2017-2022) & ($ million)
Table 9. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Type (2017-2022)
Table 10. Global Benign Prostatic Hyperplasic Device Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Benign Prostatic Hyperplasic Device Sales by Application (2017-2022) & (K Units)
Table 12. Global Benign Prostatic Hyperplasic Device Sales Market Share by Application (2017-2022)
Table 13. Global Benign Prostatic Hyperplasic Device Revenue by Application (2017-2022)
Table 14. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Application (2017-2022)
Table 15. Global Benign Prostatic Hyperplasic Device Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Benign Prostatic Hyperplasic Device Sales by Company (2020-2022) & (K Units)
Table 17. Global Benign Prostatic Hyperplasic Device Sales Market Share by Company (2020-2022)
Table 18. Global Benign Prostatic Hyperplasic Device Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Company (2020-2022)
Table 20. Global Benign Prostatic Hyperplasic Device Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Benign Prostatic Hyperplasic Device Producing Area Distribution and Sales Area
Table 22. Players Benign Prostatic Hyperplasic Device Products Offered
Table 23. Benign Prostatic Hyperplasic Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Benign Prostatic Hyperplasic Device Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Benign Prostatic Hyperplasic Device Sales Market Share Geographic Region (2017-2022)
Table 28. Global Benign Prostatic Hyperplasic Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Benign Prostatic Hyperplasic Device Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Benign Prostatic Hyperplasic Device Sales Market Share by Country/Region (2017-2022)
Table 32. Global Benign Prostatic Hyperplasic Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Benign Prostatic Hyperplasic Device Sales by Country (2017-2022) & (K Units)
Table 35. Americas Benign Prostatic Hyperplasic Device Sales Market Share by Country (2017-2022)
Table 36. Americas Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Benign Prostatic Hyperplasic Device Revenue Market Share by Country (2017-2022)
Table 38. Americas Benign Prostatic Hyperplasic Device Sales by Type (2017-2022) & (K Units)
Table 39. Americas Benign Prostatic Hyperplasic Device Sales Market Share by Type (2017-2022)
Table 40. Americas Benign Prostatic Hyperplasic Device Sales by Application (2017-2022) & (K Units)
Table 41. Americas Benign Prostatic Hyperplasic Device Sales Market Share by Application (2017-2022)
Table 42. APAC Benign Prostatic Hyperplasic Device Sales by Region (2017-2022) & (K Units)
Table 43. APAC Benign Prostatic Hyperplasic Device Sales Market Share by Region (2017-2022)
Table 44. APAC Benign Prostatic Hyperplasic Device Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Benign Prostatic Hyperplasic Device Revenue Market Share by Region (2017-2022)
Table 46. APAC Benign Prostatic Hyperplasic Device Sales by Type (2017-2022) & (K Units)
Table 47. APAC Benign Prostatic Hyperplasic Device Sales Market Share by Type (2017-2022)
Table 48. APAC Benign Prostatic Hyperplasic Device Sales by Application (2017-2022) & (K Units)
Table 49. APAC Benign Prostatic Hyperplasic Device Sales Market Share by Application (2017-2022)
Table 50. Europe Benign Prostatic Hyperplasic Device Sales by Country (2017-2022) & (K Units)
Table 51. Europe Benign Prostatic Hyperplasic Device Sales Market Share by Country (2017-2022)
Table 52. Europe Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Benign Prostatic Hyperplasic Device Revenue Market Share by Country (2017-2022)
Table 54. Europe Benign Prostatic Hyperplasic Device Sales by Type (2017-2022) & (K Units)
Table 55. Europe Benign Prostatic Hyperplasic Device Sales Market Share by Type (2017-2022)
Table 56. Europe Benign Prostatic Hyperplasic Device Sales by Application (2017-2022) & (K Units)
Table 57. Europe Benign Prostatic Hyperplasic Device Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Benign Prostatic Hyperplasic Device Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Benign Prostatic Hyperplasic Device Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Benign Prostatic Hyperplasic Device Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Benign Prostatic Hyperplasic Device Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Benign Prostatic Hyperplasic Device Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Benign Prostatic Hyperplasic Device Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Benign Prostatic Hyperplasic Device Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Benign Prostatic Hyperplasic Device Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Benign Prostatic Hyperplasic Device
Table 67. Key Market Challenges & Risks of Benign Prostatic Hyperplasic Device
Table 68. Key Industry Trends of Benign Prostatic Hyperplasic Device
Table 69. Benign Prostatic Hyperplasic Device Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Benign Prostatic Hyperplasic Device Distributors List
Table 72. Benign Prostatic Hyperplasic Device Customer List
Table 73. Global Benign Prostatic Hyperplasic Device Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Benign Prostatic Hyperplasic Device Sales Market Forecast by Region
Table 75. Global Benign Prostatic Hyperplasic Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Benign Prostatic Hyperplasic Device Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Benign Prostatic Hyperplasic Device Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Benign Prostatic Hyperplasic Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Benign Prostatic Hyperplasic Device Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Benign Prostatic Hyperplasic Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Benign Prostatic Hyperplasic Device Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Benign Prostatic Hyperplasic Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Benign Prostatic Hyperplasic Device Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Benign Prostatic Hyperplasic Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Benign Prostatic Hyperplasic Device Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Benign Prostatic Hyperplasic Device Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Benign Prostatic Hyperplasic Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Benign Prostatic Hyperplasic Device Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Benign Prostatic Hyperplasic Device Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Benign Prostatic Hyperplasic Device Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Benign Prostatic Hyperplasic Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Benign Prostatic Hyperplasic Device Revenue Market Share Forecast by Application (2023-2028)
Table 93. KARL STORZ SE Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 94. KARL STORZ SE Benign Prostatic Hyperplasic Device Product Offered
Table 95. KARL STORZ SE Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. KARL STORZ SE Main Business
Table 97. KARL STORZ SE Latest Developments
Table 98. Richard Wolf GmbH Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Richard Wolf GmbH Benign Prostatic Hyperplasic Device Product Offered
Table 100. Richard Wolf GmbH Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Richard Wolf GmbH Main Business
Table 102. Richard Wolf GmbH Latest Developments
Table 103. Olympus Corporation Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Olympus Corporation Benign Prostatic Hyperplasic Device Product Offered
Table 105. Olympus Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Olympus Corporation Main Business
Table 107. Olympus Corporation Latest Developments
Table 108. Urologix Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 109. Urologix Benign Prostatic Hyperplasic Device Product Offered
Table 110. Urologix Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Urologix Main Business
Table 112. Urologix Latest Developments
Table 113. Boston Scientific Corporation Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Boston Scientific Corporation Benign Prostatic Hyperplasic Device Product Offered
Table 115. Boston Scientific Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Boston Scientific Corporation Main Business
Table 117. Boston Scientific Corporation Latest Developments
Table 118. Butterfly Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Butterfly Benign Prostatic Hyperplasic Device Product Offered
Table 120. Butterfly Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Butterfly Main Business
Table 122. Butterfly Latest Developments
Table 123. TELEFLEX Incorporated Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 124. TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Product Offered
Table 125. TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. TELEFLEX Incorporated Main Business
Table 127. TELEFLEX Incorporated Latest Developments
Table 128. OmniGuide Holdings Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 129. OmniGuide Holdings Benign Prostatic Hyperplasic Device Product Offered
Table 130. OmniGuide Holdings Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. OmniGuide Holdings Main Business
Table 132. OmniGuide Holdings Latest Developments
Table 133. Convergent Laser Technologies Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 134. Convergent Laser Technologies Benign Prostatic Hyperplasic Device Product Offered
Table 135. Convergent Laser Technologies Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Convergent Laser Technologies Main Business
Table 137. Convergent Laser Technologies Latest Developments
Table 138. ProArc Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 139. ProArc Benign Prostatic Hyperplasic Device Product Offered
Table 140. ProArc Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. ProArc Main Business
Table 142. ProArc Latest Developments
Table 143. Olympus Corporation Basic Information, Benign Prostatic Hyperplasic Device Manufacturing Base, Sales Area and Its Competitors
Table 144. Olympus Corporation Benign Prostatic Hyperplasic Device Product Offered
Table 145. Olympus Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Olympus Corporation Main Business
Table 147. Olympus Corporation Latest Developments
List of Figures
Figure 1. Picture of Benign Prostatic Hyperplasic Device
Figure 2. Benign Prostatic Hyperplasic Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Benign Prostatic Hyperplasic Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Benign Prostatic Hyperplasic Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Benign Prostatic Hyperplasic Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Radiofrequency Ablation Devices
Figure 10. Product Picture of Urology Lasers Devices
Figure 11. Product Picture of Others
Figure 12. Global Benign Prostatic Hyperplasic Device Sales Market Share by Type in 2021
Figure 13. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Type (2017-2022)
Figure 14. Benign Prostatic Hyperplasic Device Consumed in Hospitals
Figure 15. Global Benign Prostatic Hyperplasic Device Market: Hospitals (2017-2022) & (K Units)
Figure 16. Benign Prostatic Hyperplasic Device Consumed in Clinics
Figure 17. Global Benign Prostatic Hyperplasic Device Market: Clinics (2017-2022) & (K Units)
Figure 18. Benign Prostatic Hyperplasic Device Consumed in Others
Figure 19. Global Benign Prostatic Hyperplasic Device Market: Others (2017-2022) & (K Units)
Figure 20. Global Benign Prostatic Hyperplasic Device Sales Market Share by Application (2017-2022)
Figure 21. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Application in 2021
Figure 22. Benign Prostatic Hyperplasic Device Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Company in 2021
Figure 24. Global Benign Prostatic Hyperplasic Device Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Geographic Region in 2021
Figure 26. Global Benign Prostatic Hyperplasic Device Sales Market Share by Region (2017-2022)
Figure 27. Global Benign Prostatic Hyperplasic Device Revenue Market Share by Country/Region in 2021
Figure 28. Americas Benign Prostatic Hyperplasic Device Sales 2017-2022 (K Units)
Figure 29. Americas Benign Prostatic Hyperplasic Device Revenue 2017-2022 ($ Millions)
Figure 30. APAC Benign Prostatic Hyperplasic Device Sales 2017-2022 (K Units)
Figure 31. APAC Benign Prostatic Hyperplasic Device Revenue 2017-2022 ($ Millions)
Figure 32. Europe Benign Prostatic Hyperplasic Device Sales 2017-2022 (K Units)
Figure 33. Europe Benign Prostatic Hyperplasic Device Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Benign Prostatic Hyperplasic Device Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Benign Prostatic Hyperplasic Device Revenue 2017-2022 ($ Millions)
Figure 36. Americas Benign Prostatic Hyperplasic Device Sales Market Share by Country in 2021
Figure 37. Americas Benign Prostatic Hyperplasic Device Revenue Market Share by Country in 2021
Figure 38. United States Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Benign Prostatic Hyperplasic Device Sales Market Share by Region in 2021
Figure 43. APAC Benign Prostatic Hyperplasic Device Revenue Market Share by Regions in 2021
Figure 44. China Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Benign Prostatic Hyperplasic Device Sales Market Share by Country in 2021
Figure 51. Europe Benign Prostatic Hyperplasic Device Revenue Market Share by Country in 2021
Figure 52. Germany Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Benign Prostatic Hyperplasic Device Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Benign Prostatic Hyperplasic Device Revenue Market Share by Country in 2021
Figure 59. Egypt Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Benign Prostatic Hyperplasic Device Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasic Device in 2021
Figure 65. Manufacturing Process Analysis of Benign Prostatic Hyperplasic Device
Figure 66. Industry Chain Structure of Benign Prostatic Hyperplasic Device
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)